利米特罗

{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 464382597
| IUPAC_name = 4-{(S)-hydroxy[(2R)-piperidin-2-yl]methyl}benzene-1,2-diol
| image = Rimiterol.svg
| width = 200
| image2 = Rimiterol ball-and-stick model.png

| tradename =
| pregnancy_AU = A
| pregnancy_US =
| pregnancy_category =
| legal_AU = S4
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref =
| CAS_number = 32953-89-2
| ATC_prefix = R03
| ATC_suffix = AC05
| ATC_supplemental =
| PubChem = 36283
| ChEMBL_Ref =
| ChEMBL = 1097630
| DrugBank_Ref =
| DrugBank =
| ChemSpiderID_Ref =
| ChemSpiderID = 33366
| UNII_Ref =
| UNII = 26GIW6ZLPH

| C = 12
| H = 17
| N = 1
| O = 3
| smiles = OC@@Hc(O)c1)[C@@H]2NCCCC2
| StdInChI_Ref =
| StdInChI = 1S/C12H17NO3/c14-10-5-4-8(7-11(10)15)12(16)9-3-1-2-6-13-9/h4-5,7,9,12-16H,1-3,6H2/t9-,12+/m1/s1
| StdInChIKey_Ref =
| StdInChIKey = IYMMESGOJVNCKV-SKDRFNHKSA-N
}}

利米特罗（INN：rimiterol）是第三代短效β2肾上腺素受体激动剂。该药物可通过静脉注射或气雾给药。利米特罗可用于治疗与支气管哮喘相关的支气管痉挛。

参见

• 异丙肾上腺素
• 可尔特罗

参考资料